BerandaABCL • NASDAQ
add
AbCellera Biologics Inc
Tutup sebelumnya
$3,51
Rentang hari
$3,41 - $3,63
Rentang tahun
$1,89 - $6,52
Kapitalisasi pasar
1,06 M USD
Volume Rata-Rata
3,13 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 44,85 jt | 788,18% |
Biaya operasional | 23,34 jt | 8.713,28% |
Penghasilan bersih | -8,94 jt | 73,85% |
Margin laba bersih | -19,94 | 97,06% |
Penghasilan per saham | -0,03 | 75,00% |
EBITDA | -22,46 jt | 13,76% |
Tarif pajak efektif | 54,13% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 533,83 jt | -14,67% |
Total aset | 1,36 M | -0,26% |
Total liabilitas | 390,05 jt | 28,11% |
Total ekuitas | 966,90 jt | — |
Saham yang beredar | 303,16 jt | — |
Harga terhadap nilai buku | 1,09 | — |
Tingkat pengembalian aset | -5,27% | — |
Tingkat pengembalian modal | -6,45% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -8,94 jt | 73,85% |
Kas dari operasi | -34,74 jt | -334,29% |
Kas dari investasi | 75,14 jt | 110,45% |
Kas dari pembiayaan | 4,12 jt | -0,65% |
Perubahan kas bersih | 44,80 jt | 50,92% |
Arus kas bebas | -6,97 jt | 90,38% |
Tentang
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Didirikan
2012
Kantor pusat
Situs
Karyawan
562
